AIG Hospitals will present a range of advanced, in-house developed AI solutions at the India AI Impact Summit, focusing on gastroenterology, radiology, critical care, and oncology. The showcase highlights real-time AI assistance during endoscopy, predictive deterioration alerts, automated imaging interpretation, and precision oncology support—demonstrating measurable improvements in diagnostic accuracy, speed, and patient safety.
Glimpse:
AIG’s AI portfolio includes deep-learning models for polyp/lesion detection in endoscopy, early sepsis and organ failure prediction, AI-assisted CT/MRI reads, smart report generation, and tumor board decision support. Already live across AIG facilities, these tools have reduced missed findings, shortened reporting times, and lowered critical care complications. The summit demo positions AIG as a frontrunner in clinically integrated, India-relevant AI adoption within tertiary hospitals.
AIG Hospitals, renowned for its leadership in gastroenterology and advanced multispecialty care, is set to unveil several cutting-edge AI-powered clinical solutions at the India AI Impact Summit. The hospital group has invested heavily in developing and validating AI tools that are deeply embedded in daily clinical workflows, delivering tangible benefits in high-volume, high-stakes specialties.
Solutions to be demonstrated include:
AI-assisted endoscopy suite real-time detection and characterization of polyps, ulcers, and precancerous lesions during colonoscopy and gastroscopy, significantly boosting adenoma detection rates Predictive patient monitoring continuous analysis of vitals, labs, and trends to provide early alerts for sepsis, acute kidney injury, respiratory failure, and hemodynamic instability in ICUs Radiology AI workflow automated preliminary reads and flagging of critical findings on abdominal CT, liver MRI, chest X-ray, and endoscopy images to prioritize urgent cases Intelligent reporting engine AI-generated structured reports with natural language summaries, reducing documentation burden for radiologists and endoscopists Precision oncology toolkit support for multidisciplinary tumor boards with therapy response prediction, genomic interpretation assistance, and personalized pathway recommendations
AIG reports strong early outcomes: higher polyp detection, earlier intervention in deteriorating patients, faster turnaround on imaging reports, and improved protocol adherence. All solutions are designed with clinician-in-the-loop oversight, transparency of AI decisions, bias mitigation, and full compliance with ABDM, data privacy, and ethical AI guidelines.
The summit presentation will feature live demos, real-world case examples, and performance metrics, showcasing how AIG is translating AI from concept to routine clinical impact. It reinforces the hospital’s strategy of building India-centric AI tools that address local disease patterns, workflow realities, and resource constraints while maintaining global standards.
“We are not waiting for the future of AI in medicine we are building and using it today to make every diagnosis sharper and every intervention safer.”
By
HB Team
